Italfarmaco partners with Iktos on artificial intelligence to speed drug discovery breakthroughs for patients
18 juin 2024 03h00 HE
|
IKTOS
PRESS RELEASE Italfarmaco partners with Iktos on artificial intelligence to speed drug discovery breakthroughs for patients Combines AI to increase the potential of novel histone deacetylase (HDAC)...
Iktos announces the appointment of Roman Fleck as Chairman of the Board
02 mai 2024 02h45 HE
|
IKTOS
Paris (France), 2nd May 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the appointment of Roman Fleck as Chairman of the Board. Yann Gaston-Mathé steps...
Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
14 févr. 2024 03h00 HE
|
IKTOS
Paris (France) and Tokyo (Japan), February 14, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces the opening of Iktos K.K., its new subsidiary in Japan....
Iktos announces the appointment of Avirup Bose as Chief Business Officer
18 janv. 2024 02h30 HE
|
IKTOS
Iktos announces the appointment of Avirup Bose as Chief Business Officer Paris (France), 18 January, 2024 – Iktos, a company specialized in Artificial Intelligence for new drug design, announces...
Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Sustainable Crop Protection Solutions
14 déc. 2023 02h30 HE
|
IKTOS
Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Sustainable Crop Protection Solutions Paris, France, December 14, 2023 – Iktos, a company specialized...
Correction: Kissei introduces Iktos AI Drug Discovery System
04 juil. 2023 11h25 HE
|
IKTOS
Kissei introduces Iktos AI Drug Discovery System Paris, France, July 3, 2023 – Iktos, a company specialized in Artificial Intelligence for new drug design, today announced that Kissei...
Kissei introduces Iktos AI Drug Discovery System
03 juil. 2023 05h20 HE
|
IKTOS
Kissei introduces Iktos AI Drug Discovery System Paris, France, July 3, 2023 – Iktos, a company specialized in Artificial Intelligence for new drug design, today announced that Kissei Pharmaceutical...